ADCT was upgraded from Neutral to Buy, UBS said. $10.50 price target. Estimates also boosted, as the company has sales drivers and continues to cut costs.
ATU was upgraded from Market Perform to Outperform, Wells Fargo said. Company is seeing improving trends in both Industrial and Energy segments.
Coverage of BEN was started with a Buy rating, UBS said. $136 price target. Company is positioned well to grow under most market conditions.
BLK was initiated with a Buy rating, UBS said. $210 price target. Company has a premier brand and should benefit from cyclical growth trends in the industry.
BWA was upgraded from Hold to Buy, Deutsche Bank said. Stock has pulled back from its recent highs, even though the company had a good quarter.
CNP was downgraded from Buy to Hold, Jefferies said. Valuation call, based on a $15.50 price target.
CNP was upgraded to Outperform, BMO Capital Markets said. $17 price target. Have increased confidence in the company's ability to grow earnings.
CTB was upgraded from Hold to Buy, Deutsche Bank said. Company can continue to grow, even if Europe slows down.
FAST, a leading North American industrial supplier, initiated with a Neutral rating and $63 price target. Premier growth play within industrial distribution, Barclays said.
GLW was initiated with a Buy rating, Sterne Agee said. $24 price target. Gross margins should continue to rebound.
HLS was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call, as the stock is up 64% since June 2009.
JCI was upgraded from Hold to Buy, Deutsche Bank said. Estimates also boosted, given the company's strong operating momentum.
JNPR was initiated with a Hold rating, ThinkEquity said. Valuation call. Company can gain market share, despite operating in a competitive environment.
MDP coverage initiated at Credit Suisse with a Neutral rating and $38 price target. MDP poised to return to growth in 2011, analysts said.
MTH upgraded to Buy from Hold and price target raised a dollar to $27. Valuation with a catalyst call, Citigroup said. 2010 and 2011 EPS estimates jumped to $0.62 and $1.55, respectively.
MU was initiated with a Buy rating, Sterne Agee said. $13 price target. DDR3 gives the company an advantage over the competition in Taiwan.
NFX initiated with a Buy rating and $66 price target. Newfield is well positioned to post over 10% production growth over at least the next three years, Citigroup said.
ODFL upgraded at Piper Jaffray. Rating raised to Overweight from Underweight. Price target raised to $43 from $32. Maintains 2010 EPS estimates of $1.47.
SIRO upgraded to Outperform from Neutral as yesterday's selloff in reaction to 2Q10 earnings was unwarranted. Product cycle still has legs, Credit Suisse said. Price target increased to $45 from $38.
Coverage of SNDK was started with a Buy rating, Sterne Agee said. $50 price target. Company has multiple positive tailwinds.
SWM was downgraded from Outperform to Perform, Oppenheimer said. Stock is up 33% since late March.
TIE was upgraded from Neutral to Buy, Longbow Research said. $20 price target. Titanium market is benefiting from the cyclical upturn in commercial aerospace.
TROW was initiated with a Neutral rating, UBS said. $62 price target. Company has less exposure in indexes, ETFs and alternative investments.
TRW was upgraded from Hold to Buy, Deutsche Bank said. Company had a strong quarter and 2011 estimates were materially increased.
WR was downgraded to Equal-weight, Morgan Stanley said. Valuation call, based on a $23.75 price target.
WY was upgraded from Hold to Buy, Argus Research said. $59 price target. Company is about to turn profitable, following two years of losses.
AAWW estimates were boosted through 2012, Goldman Sachs said. Company is seeing higher interest income. Neutral rating and $64 price target.
Alliance Data Systems price target lifted at Barclays
ADS price target improved to $85 from $82 after meeting with ADS' CFO confirmed their ability to achieve earnings, Barclays said. Reiterate Overweight rating.
ADS price target improved to $85 from $82 after meeting with ADS' CFO confirmed their ability to achieve earnings, Barclays said. Reiterate Overweight rating.
AYE price target reduced to $23 from $25 on lower than expected earnings, Barclays said. 2010 and 2011 EPS estimates sunk to $2.05 and $2.10, respectively. Maintain Overweight rating.
BMC estimates were cut through 2012, according to Goldman Sachs. Company is seeing lower sales. Neutral rating and $43 price target.
Shares of CBS now seen reaching $14.50, according to Goldman Sachs. Estimates also upped, as the company is seeing better network trends. Neutral rating.
CSCO price target improved to $35 from $32 on expectations of a strong 3Q10, Credit Suisse said. Ongoing improvement in enterprise network trends. Outperform rating,
DGI price target lifted to $29 from $26 as 1Q10 results were ahead of expectations, Citigroup said. 2010 and 2011 EPS estimates increased to $0.53 and $1.24, respectively. Maintain Hold rating.
DVN price target increased to $77 from $74 as it plans to repurchase up to $3.5 billion of shares, Barclays said. 2010 EPS estimate trimmed to $5.20, 2011 raised to $4.00. Maintain Equal Weight rating.
DVN estimates were increased through 2011, according to Morgan Stanley. Company is seeing higher production rates and keeping costs in check. Equal-weight rating.
EDMC estimates were raised through 2012, Goldman Sachs said. Company is seeing strong enrollment rates and has operating leverage. Neutral rating and new $23 price target.
EXC estimates were cut through 2014, Goldman Sachs said. Incremental hedging is cutting into profits. Neutral rating and new $45 price target.
EXPD price target jumped from $38 to $48 on strong 1Q10 results, Citigroup said. 2010 and 2011 EPS estimates raised to $1.25 and $1.45, respectively. Maintain Buy rating.
Shares of EXPD now seen reaching $47, according to UBS. Estimates also increased, as the company is seeing higher freight volumes. Buy rating.
FWLT price target lowered by a dollar to $37 on mixed 1Q10 results and higher near-term risk, Barclays said. 2010 and 2011 EPS estimates lowered to $2.20 and $2.40, respectively. Maintain Overweight rating.
Shares of ICE now seen reaching $143, according to UBS. Estimates also upped, as the company is seeing record volume and commission levels. Buy rating.
KG estimates were reduced through 2012, Goldman Sachs said. Company is seeing lower sales and also lacks catalysts. Sell rating and new $9.50 price target.
MCHP estimates were raised through 2012, Morgan Stanley said. Company boosted guidance, but the SST purchase does add an overhang to the stock. Equal-weight rating.
MUR estimates were cut through 2011, UBS said. Company is being hurt by currency rates. Neutral rating and $58 price target.
ONNN estimates were increased through 2012, according to Morgan Stanley. Company boosted guidance and should continue to grow its gross margin. Underweight rating.
PHM estimates were raised through 2011, UBS said. Company should benefit as the market stabilizes. Sell rating and new $9 price target.
PRU price target increased to $57 from $53 as the company reported another quarter of very strong operations, Barclays said. 2010 and 2011 EPS estimates lifted to $5.81 and $6.60, respectively. Maintain Equal Weight rating.
PXD estimates were upped through 2012, Morgan Stanley said. Company is seeing ramping production growth. Equal-weight rating.
Shares of Q now seen reaching $5.75, FBR Capital Markets said. Company is seeing higher enterprise sales and continues to control costs. Market Perform rating.
QSFT estimates were raised through 2012, Goldman Sachs said. Company is seeing a lower tax rate and is expected to buy back more stock. Sell rating and $16.50 price target.
SBAC estimates were cut through 2011, according to Morgan Stanley. Domestic site leasing business could slow. Equal-weight rating.
Shares of SO now seen reaching $34, according to Goldman Sachs. Estimates also increased, given the company's new guidance. Neutral rating.
Shares of SPW now seen reaching $68, according to FBR Capital Markets. Estimates also upped, as the company is seeing better Test & Measurement results. Market Perform rating.
SYMC estimates were lowered through 2011, according to FBR Capital Markets. Company faces currency headwinds and faces dilution following its recent acquisitions. Outperform rating and $20 price target.
SYMC estimates were boosted through 2012, Morgan Stanley said. Company is seeing sales growth across the board. Equal-weight rating and $20 price target.
THC estimates were raised through 2011, Morgan Stanley said. Cost-cutting is offsetting lower admission levels. Underweight rating.
TWX 2010 and 2011 EPS estimates inflated to $2.21 and $2.57, respectively, on a solid start to 2010, Bank of America/Merrill Lynch said. Reiterate Neutral rating and $34 price target.
Shares of TWX now seen reaching $36, according to Goldman Sachs. Estimates also increased, given higher results in advertising, cable networks and publishing. Buy rating.
TWX price target raised to $32 from $30, Barclays said. Reiterate Equal Weight rating.
VALE estimates were boosted through 2011, Morgan Stanley said. Company is seeing higher prices in the ferrous division. Overweight rating and $38 price target.